Premium
The Free Cued Selective Reminding Test detects episodic memory impairment in the presymptomatic period of familial frontotemporal dementia within the GENFI cohort
Author(s) -
Poos Jackie M.,
Russell Lucy L,
Peakman Georgia,
Moore Katrina M.,
Greaves Caroline V.,
Bocchetta Martina,
Jiskoot Lize C.,
Moreno Fermin,
SanchezValle Raquel,
Borroni Barbara,
Laforce Robert,
Masellis Mario,
Tartaglia Carmela,
Graff Caroline,
Galimberti Daniela,
Rowe James B.,
Finger Elizabeth,
Synofzik Matthis,
Vandenberghe Rik,
Mendonca Alexandre,
Tagliavini Fabrizio,
Santana Isabel,
Ducharme Simon,
Butler Christopher,
Gerhard Alexander,
Levin Johannes,
Danek Adrian,
Otto Markus,
Papma Janne M.,
van den Berg Esther,
van Swieten John C.,
Rohrer Jonathan D.
Publication year - 2020
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1002/alz.045768
Subject(s) - frontotemporal dementia , psychology , c9orf72 , cohort , recall , episodic memory , dementia , free recall , audiology , medicine , psychiatry , cognition , disease , cognitive psychology
Background Episodic memory is increasingly reported in frontotemporal dementia (FTD) and it has been suggested to differ between genetic forms of FTD. However, systematic investigations of episodic memory in familial FTD, and specifically the presymptomatic stage, are scarce. This cross‐sectional study investigates performance on the Free Cued and Selective Reminding Test (FCSRT) in the Genetic Frontotemporal Dementia Initiative (GENFI), a large familial FTD cohort. Method 685 participants were tested with the FCSRT (52 presymptomatic and 21 symptomatic MAPT , 135 presymptomatic and 42 symptomatic GRN , 109 presymptomatic and 63 symptomatic C9orf72 mutation carriers and 263 non‐carriers). The presymptomatic mutation carriers were split into an early and late presymptomatic period (more than or within ten years of expected symptom onset). Groups were compared using linear regression models, adjusted for age and education, with bootstrapping. Result Performance on all FCSRT test scores had a negative correlation with age (0.18 > r < 0.38) and immediate free recall ( r = 0.21), immediate total recall ( r = 0.14) and delayed free recall ( r = 0.24) had a positive correlation with education. All symptomatic mutation carrier groups scored significantly lower than controls on immediate free recall ( MAPT : −2.54 ± 1.52; GRN : −3.15 ± 2.13; C9orf72 : −2.67 ± 1.32), immediate total recall ( MAPT : −4.83 ± 4.42; GRN : −6.65 ± 5.69; C9orf72 : −3.63 ± 3.99), delayed free recall ( MAPT : −2.66 ± 1.98; GRN : −3.08 ± 2.17; C9orf72: −2.64 ± 1.41) and delayed total recall ( MAPT : −4.32 ± 4.49; GRN : −6.48 ± 6.63; C9orf72 : −4.32 ± 4.49). In the presymptomatic group, C9orf72 participants performed significantly lower on immediate (late: −0.75 ± 0.93) and delayed free recall (early: −0.11 ± 1.12; late: −0.57 ± 1.14) measures. Conclusion Episodic memory is impaired in genetic FTD, with decline already starting in the presymptomatic period in C9orf72 mutation carriers. The differences between mutation carriers groups in free versus cued recall formats corroborates the notion that the clinical presentation of episodic memory deficits (i.e. as a result of executive impairment versus “true” consolidation problems) in FTD depend on the underlying mutation, and thus atrophy pattern. Our next step is to replicate results in a larger dataset and correlate performance on the FCSRT to grey matter density in each genetic group using voxel‐based morphometry.